Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06725511 · ClinicalTrials.gov registry record · NA
Wellness Program Outreach and Effectiveness
A NA study of Metabolic Syndrome, sponsored by Massachusetts Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT06725511: Recruiting NA study of Metabolic Syndrome, sponsored by Massachusetts Institute of Technology.
NCT06725511 is a NA study of Metabolic Syndrome that is actively recruiting participants, run by Massachusetts Institute of Technology. The registered enrollment target is 2,000 participants, above the 1,185-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06725511, a NA study of Metabolic Syndrome, is actively recruiting participants, sponsored by Massachusetts Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellness and disease-management programs have the potential to improve wellbeing and reduce healthcare costs, their effectiveness is often undermined by low engagement and selection bias in participant comparisons. This study will test whether an outreach approach that auto-enrolls eligible individuals-employees and their spouses/domestic partners-into the program, with the option to opt out, can increase engagement and improve health outcomes compared to the standard invitation-based approach.
Primary Outcome
The outcome is whether participants begin the program at some point during the Annual Risk Assessment year.
Conditions Studied
Interventions
- BEHAVIORAL Opt-out framing
- BEHAVIORAL Opt-in framing
Study Locations (1)
New Jersey
- Quest Diagnostics - Secaucus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06725511 shows while recruiting
NCT06725511 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,185-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (69% higher).
The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Opt-out framing is the first listed.
NCT06725511 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06725511 about?
NCT06725511 is a clinical study titled "Wellness Program Outreach and Effectiveness". The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellne...
What is the current status of trial NCT06725511?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2024-10-02. Estimated completion is 2026-08-31.
What conditions does trial NCT06725511 study?
This clinical trial studies the following conditions: Metabolic Syndrome.
What interventions are being tested in trial NCT06725511?
The interventions under investigation include: Opt-out framing (BEHAVIORAL), Opt-in framing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06725511?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06725511 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06725511's enrollment target sits among peer trials
2,000 8th of 102 higher than 95 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI